Robert W. Myers

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Tri-Institutional Therapeutics Discovery Institute

ChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential”.

Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential

Frontiers in Physiology(2022)10.3389/fphys.2022.1013845

N/A

0.396DataRank · unranked

13 citations

Jacob Ferreira, Lubna Ghanem, Hannes Buck, Clemens Steegborn, Robert W. Myers +4 more

Deglycase-activity oriented screening to identify DJ-1 inhibitors

RSC Medicinal Chemistry(2021)10.1039/d1md00062d

N/A

0DataRank · unranked

21 citations

Efrat Finkin-Groner, Yoshiyuki Fukase, Qingfei Zheng, Shan Sun, Mayako Michino +4 more

On-demand male contraception via acute inhibition of soluble adenylyl cyclase

Nature Communications(2023)10.1038/s41467-023-36119-6

N/A

0DataRank · unranked

83 citations

Thomas Rossetti, Jacob Ferreira, Lubna Ghanem, Carla Ritagliati, Robert W. Myers +7 more

Using a function-first ‘scout fragment’-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.25.559391

N/A

0DataRank · unranked

1 citations

Patrick M. M. Shelton, Tyler K. Heiss, Paul Dominic B. Olinares, Lauren E. Vostal, Heather Soileau +11 more